The global Positron Emission Tomography (PET) System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Positron Emission Tomography (PET) System is a high-end nuclear medical imaging device primarily used to obtain metabolic and functional information of internal organs and tissues in the human body. The system operates based on the distribution of radiotracer-labeled radionuclides within the body. By detecting gamma rays generated from the annihilation of emitted positrons with electrons, it reconstructs a three-dimensional image of metabolic activity. PET systems are capable of identifying abnormalities at the cellular and molecular levels, making them particularly valuable in the diagnosis of tumors, analysis of neurological disorders, and evaluation of cardiovascular diseases. Compared to traditional imaging modalities such as CT or MRI, PET emphasizes functional imaging over anatomical structure. Therefore, it is often integrated with CT or MRI (e.g., PET-CT, PET-MRI) to combine both anatomical and metabolic information. With the advancement of precision medicine and molecular imaging, the demand for PET systems in clinical and research applications continues to grow, driving ongoing innovation in related equipment, radiotracers, and image processing technologies. As such, PET systems have become an indispensable tool in the field of modern medical imaging.

Market Development Opportunities & Main Driving Factors

With the aging global population and the rising incidence of chronic diseases, demand for Positron Emission Tomography (PET) systems continues to grow in the context of precision diagnosis and treatment, particularly for early cancer screening, cardiovascular conditions, and neurodegenerative disorders. Technological advancements in molecular imaging, the development of novel radiotracers, and supportive national policies aimed at medical equipment localization are key drivers expanding the PET system market. Notably, the emergence of multi-modality imaging devices such as PET/CT and PET/MRI has created new growth momentum for the industry.

Market Challenges, Risks, & Restraints

Despite its strong market potential, PET systems are high-cost, high-precision medical devices that require substantial investment, advanced technology, and a well-developed supply chain. Core components such as high-performance detectors and key algorithms remain heavily dependent on imports, slowing domestic substitution efforts. Moreover, strict regulations surrounding the use and handling of radioactive drugs, coupled with complex infrastructure requirements, create high barriers to market entry. Reimbursement limitations and constrained hospital procurement budgets may also hinder the pace of market adoption.

Downstream Demand Trends

The increasing clinical demand for early screening and diagnosis is driving broader adoption of PET systems in tertiary hospitals and regional medical centers. In the research sector, PET is becoming essential for brain function imaging and pharmacokinetics studies. Meanwhile, the integration of artificial intelligence in image reconstruction and lesion detection is accelerating the development of more intelligent and automated PET systems. Looking ahead, the growing emphasis on personalized treatment and precision medicine is expected to further deepen the application of advanced PET technologies in specialized medical fields.

Infinity Market Research newest research report, the Positron Emission Tomography (PET) System Industry Forecast looks at past sales and reviews total world Positron Emission Tomography (PET) System sales in 2024, providing a comprehensive analysis by region and market sector of projected Positron Emission Tomography (PET) System sales for 2025 through 2031. With Positron Emission Tomography (PET) System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Positron Emission Tomography (PET) System industry.

This Insight Report provides a comprehensive analysis of the global Positron Emission Tomography (PET) System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Positron Emission Tomography (PET) System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Positron Emission Tomography (PET) System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Positron Emission Tomography (PET) System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Positron Emission Tomography (PET) System.

This report presents a comprehensive overview, market shares, and growth opportunities of Positron Emission Tomography (PET) System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Direct Imaging
    Indirect Imaging
    Alternative Imaging

Segmentation by Application:

    Tumor Diagnosis
    Coronary Heart Disease (CHD) Diagnosis
    Brain Disease Diagnosis

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    GE Healthcare
    Siemens Healthineers
    Philips Healthcare
    Canon Medical Systems
    Hitachi Medical
    Shimadzu Corporation
    Ray Vision Intl
    Boston Scientific
    SynchroPET
    Zecotek Photonics
    Brain Biosciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global Positron Emission Tomography (PET) System market?
What factors are driving Positron Emission Tomography (PET) System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Positron Emission Tomography (PET) System market opportunities vary by end market size?
How does Positron Emission Tomography (PET) System break out by Type, by Application?